Skip Navigation
  Search Menu
Find an Expert


Michael Adam Gorin, M.D.

4.6 out of 5
114 Ratings
Photo of Dr. Michael Adam Gorin, M.D.

Director of the Prostate Cancer Precision Medicine Center of Excellence

Assistant Professor of Urology

Specializes in: Adults (18+ years)


Expertise: Ablation, Active Surveillance of Prostate Cancer, Advanced Laparoscopy, Benign Prostatic Hyperplasia (BPH), Cryosurgery, Kidney biopsy , Kidney Cancer, Kidney Stones, Kidney Tumors, Laparoscopic Kidney Surgery, Lower Urinary Tract Obstruction, Minimally Invasive Surgery, Prostate Cancer, Prostate Disease, Robotic Prostatectomy, Robotic Surgery, Urology more

Request an Appointment

I live in Maryland

Request an appointment through MyChart!

I live outside of Maryland

Request Appointment

I live outside of the United States

Request Appointment


The Johns Hopkins Hospital


600 N. Wolfe Street Park 213 Baltimore, MD 21287 map

Phone: 410-502-7710 | Fax: 410-502-7711



  • Director of the Prostate Cancer Precision Medicine Center of Excellence
  • Director of Clinical Operations
  • Director of Urology Clinical Trials
  • Co-Director of the Prostate Cancer Multidisciplinary Clinic
  • Assistant Professor of Urology
  • Assistant Professor of Oncology
  • Assistant Professor of Pathology
  • Assistant Professor of Radiology and Radiological Science



  • MD, University of Miami Miller School of Medicine (2011)


  • Johns Hopkins University School of Medicine / Urology (2017)

Board Certifications

  • Pending/Scheduled / Urology

Research & Publications

Selected Publications

View all on Pubmed

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME. PSMA-targeted 18F-DCFPyL PET/CT in the preoperative staging of men with high-risk prostate cancer: results of a prospective phase II single-center study. J Urol 2017; in press

Gorin MA, Rowe SP, Denmeade SR. Clinical applications of molecular imaging in the management of prostate cancer. PET Clin 2017; 12: 185-192

Gorin MA, Rowe SP, Baras A, Solnes L, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME. Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors. Eur Urol 2016; 69(3): 413-6

Gorin MA, Pomper MG, Pienta KJ, Rowe SP. Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer. BJU Int 2017; 120(2): 160-161

Rowe SP, Javadi MS, Allaf ME, Gorin MA. Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality? EJNMMI Res 2017; 7(1): 34

Activities & Honors


  • American Urological Association, 2011

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile